Mutations, methylation and expression of CDKN2 alpha/p16 gene in colorectal cancer and normal colonic mucosa

Citation
L. Trzeciak et al., Mutations, methylation and expression of CDKN2 alpha/p16 gene in colorectal cancer and normal colonic mucosa, CANCER LETT, 163(1), 2001, pp. 17-23
Citations number
29
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
163
Issue
1
Year of publication
2001
Pages
17 - 23
Database
ISI
SICI code
0304-3835(20010210)163:1<17:MMAEOC>2.0.ZU;2-P
Abstract
The status of CDKN2 alpha gene, coding for p16 and p19ARF proteins, was exa mined in 55 colorectal cancers. Polymerase chain reaction (PCR), single str anded conformational polymorphism and sequencing revealed 1 case of CDKN2 a lpha mutation. Methylation-specific PCR detected p16 locus methylation in 3 7 (73%) of 51 normal samples and 29 (53%) of 55 cancers (P = 0.035). p16 tr anscript absence (assessed by reverse transcription-polymerase chain reacti on) was noted in 10 (45%) of 22 normal samples and four (14%) of 29 cancers (P = 0.012) and correlated with gene methylation (P = 0.036). The decreasi ng frequency of p16 silencing in cancer comparing to normal mucosa does not support the postulated role of p16 in colorectal carcinogenesis. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.